LIVI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.135
EU - Europa 15.461
AS - Asia 10.233
SA - Sud America 1.518
AF - Africa 218
OC - Oceania 198
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 2
Totale 51.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.908
RU - Federazione Russa 6.177
SG - Singapore 3.028
PL - Polonia 2.756
CN - Cina 2.613
IT - Italia 1.954
HK - Hong Kong 1.869
IE - Irlanda 1.313
BR - Brasile 1.250
KR - Corea 1.107
SE - Svezia 1.077
DE - Germania 592
VN - Vietnam 458
FI - Finlandia 351
FR - Francia 348
IN - India 336
GB - Regno Unito 308
JO - Giordania 242
AU - Australia 193
UA - Ucraina 193
ID - Indonesia 132
CA - Canada 129
AR - Argentina 103
ES - Italia 103
TR - Turchia 81
CH - Svizzera 71
NL - Olanda 71
BD - Bangladesh 60
JP - Giappone 60
MX - Messico 58
CI - Costa d'Avorio 57
EC - Ecuador 44
IQ - Iraq 41
ZA - Sudafrica 41
BE - Belgio 38
MA - Marocco 29
CZ - Repubblica Ceca 28
VE - Venezuela 28
PK - Pakistan 27
CO - Colombia 23
PE - Perù 20
EG - Egitto 19
PY - Paraguay 19
IL - Israele 17
LT - Lituania 17
KZ - Kazakistan 16
UZ - Uzbekistan 16
PH - Filippine 15
AZ - Azerbaigian 14
HU - Ungheria 13
AT - Austria 12
CL - Cile 12
DZ - Algeria 12
TN - Tunisia 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 11
BJ - Benin 10
DO - Repubblica Dominicana 10
SC - Seychelles 10
IR - Iran 9
KE - Kenya 9
KG - Kirghizistan 9
BG - Bulgaria 8
GR - Grecia 7
BO - Bolivia 6
NP - Nepal 6
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
DK - Danimarca 4
EU - Europa 4
HN - Honduras 4
LB - Libano 4
MM - Myanmar 4
OM - Oman 4
PA - Panama 4
RO - Romania 4
SN - Senegal 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
CR - Costa Rica 3
CY - Cipro 3
DM - Dominica 3
GE - Georgia 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AL - Albania 2
AM - Armenia 2
AQ - Antartide 2
BW - Botswana 2
BY - Bielorussia 2
ET - Etiopia 2
GD - Grenada 2
JM - Giamaica 2
KW - Kuwait 2
Totale 51.735
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.290
Warsaw 2.739
Fairfield 2.458
Ashburn 2.331
Singapore 2.010
Hong Kong 1.590
Chandler 1.357
Dublin 1.311
Woodbridge 1.125
Seoul 1.099
Seattle 1.071
Cambridge 974
Houston 938
Wilmington 797
Hefei 711
Beijing 654
Lawrence 443
Florence 429
Altamura 420
Ann Arbor 413
Buffalo 391
Princeton 359
Los Angeles 321
Munich 293
Jacksonville 281
Moscow 251
Paris 224
Boston 220
New York 191
Mumbai 186
Melbourne 183
Shanghai 162
Medford 157
Dearborn 155
Kent 151
Ho Chi Minh City 150
San Diego 142
Boardman 140
São Paulo 127
Clifton 118
Dallas 113
The Dalles 105
Milan 86
Hanoi 83
Jakarta 83
Turku 73
Redondo Beach 71
London 67
Rome 65
Bern 61
Helsinki 59
Abidjan 57
Falls Church 57
Barcelona 56
Frankfurt am Main 55
Tokyo 47
Toronto 47
Izmir 45
Norwalk 44
Dong Ket 43
Brooklyn 41
Chicago 41
Brussels 36
Stockholm 36
Bengaluru 35
Denver 35
Guangzhou 35
Phoenix 35
Belo Horizonte 33
Tianjin 33
Hillsboro 32
Yubileyny 32
Lappeenranta 30
Montreal 30
San Francisco 29
Andover 27
Pune 27
West Jordan 27
Rio de Janeiro 26
Redwood City 24
Brasília 23
Johannesburg 23
Poplar 23
Atlanta 21
Baghdad 20
Chennai 20
Shenzhen 20
Orem 19
Quito 19
Campinas 18
Lauterbourg 18
Nanjing 18
Porto Alegre 18
Bologna 17
Brno 17
Buenos Aires 17
Da Nang 17
Haiphong 17
Ottawa 17
Portsmouth 17
Totale 34.702
Salva come PNG Salva come JPEG
Nome #
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study 318
Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study 316
Quality of Life and Sexual Health in the Aging of PCa Survivors. 304
Raccomandazioni cliniche per il carcinoma mammario 303
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 292
Head and neck reconstruction with pedicled flaps in the free flap era. 279
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 274
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 272
Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study 271
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 267
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 264
A multiparametric method to assess the MIM deformable image registration algorithm 252
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 248
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 242
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 241
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 240
Radiosensitivity in the breast cancer management scenario: Another step forward? 239
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 236
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 236
Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases. 235
In Regard to Vaidya et al 231
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 226
Operator-dependent reproducibility of size measurements of small phantoms and lung nodules examined with low dose thin-section 225
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 218
Prognosis of men with penile metastasis and malignant priapism: a systematic review. 215
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 214
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 213
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 209
ADAM: A breathing phantom for lung SBRT quality assurance 208
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 207
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 207
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 205
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 204
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 200
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 199
ADAM phantom to test 4D medical imaging and dose delivery devices 199
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 197
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 197
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 195
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 194
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 194
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 193
Auto-planning for VMAT accelerated partial breast irradiation 191
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 191
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 190
Interim PET after Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 189
Influence of age and subtype in outcome of operable liposarcoma 189
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. 186
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 186
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 185
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 185
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer. 184
A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix 183
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 183
Cervicoisthmic choriocarcinoma mimicking cesarean section scar ectopic pregnancy 182
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 182
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. 182
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 181
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 179
Breast cancer in the elderly: treatment of 1500 patients. 178
Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study 178
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 177
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 176
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 175
Radiotherapy in the age of cancer immunology: Current concepts and future developments 174
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 174
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 173
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 173
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 173
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 172
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 172
Use of tamoxifen in pT1a-pT1b, pN0 breast cancer. 172
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 171
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 171
Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. 170
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 170
Role of core needle biopsy in primary breast lymphoma 169
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 169
Uterine sarcoma: twenty-seven years of experience. 168
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 168
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 168
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 167
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 167
Cancer stem cells: biology and potential therapeutic applications 166
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 165
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 165
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 164
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 164
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 164
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 164
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 162
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. 162
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 162
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 162
Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution 162
Regorafenib in glioblastoma recurrence: A case report 161
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment. 161
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab expanded access program (EAP) in Italy 161
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 161
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 160
Totale 19.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.846 0 0 0 0 0 277 187 226 311 428 233 184
2021/20222.233 58 175 189 130 71 111 83 198 98 111 390 619
2022/20236.166 565 1.252 262 348 451 1.051 775 414 685 63 170 130
2023/20242.592 109 252 368 137 166 365 116 581 53 134 206 105
2024/202517.072 623 1.685 1.048 2.739 4.892 1.977 304 985 824 534 632 829
2025/202610.635 2.095 2.581 1.747 1.687 2.271 254 0 0 0 0 0 0
Totale 52.243